Overview
The pharmaceutical industry operates under some of the most stringent regulatory frameworks in the world. FDA compliance, clinical trial regulations, manufacturing standards, and post-market surveillance requirements are non-negotiable—and violations can halt product launches, trigger recalls, and result in significant penalties. This virtual seminar equips regulatory affairs professionals, quality assurance teams, and manufacturing leaders with the knowledge to navigate FDA requirements, manage regulatory submissions, and maintain compliance throughout the product lifecycle. You'll learn the regulatory pathways that matter most, understand documentation requirements, and implement systems that keep your organization ahead of compliance risk.
Why Should You Attend
- Master FDA regulatory pathways and understand which requirements apply to your products and operations
- Accelerate product approvals by understanding FDA submission requirements and documentation standards
- Reduce compliance risk by implementing quality systems that satisfy FDA inspections and audits
- Navigate post-market surveillance and adverse event reporting obligations with confidence
- Stay current on evolving FDA guidance and regulatory changes that impact your programs
- Build credibility with regulatory agencies through proper documentation and transparent communication
- Protect your organization from warning letters, recalls, and enforcement actions
Key Takeaways
- FDA regulatory pathways (510(k), PMA, NDA) and how to determine the correct pathway for your products
- Clinical trial regulations and IND requirements for investigational pharmaceutical products
- Manufacturing compliance standards including cGMP requirements and quality system documentation
- Post-market surveillance obligations, adverse event reporting, and pharmacovigilance requirements
- Documentation standards and record-keeping practices that satisfy FDA inspections
Who Should Attend
- Regulatory affairs professionals managing FDA submissions and compliance programs
- Quality assurance managers responsible for manufacturing compliance and FDA audits
- Clinical operations leaders managing investigational drug trials and IND submissions
- Manufacturing directors ensuring cGMP compliance and product quality standards
- Compliance officers overseeing pharmaceutical regulatory risk and audit preparation
Learning Objectives
- You will be able to identify the correct FDA regulatory pathway for pharmaceutical products and determine submission requirements
- You will be able to prepare regulatory submissions that meet FDA documentation standards and increase approval likelihood
- You will be able to implement manufacturing and quality systems that satisfy cGMP requirements and FDA inspections
- You will be able to manage post-market surveillance and adverse event reporting obligations correctly
About the Speaker
Charles H. Paul is a pharmaceutical regulatory affairs specialist with extensive experience navigating FDA requirements and managing product approvals. He has guided companies through clinical trials, regulatory submissions, and manufacturing compliance across multiple therapeutic areas. Charles's expertise spans the entire pharmaceutical product lifecycle, from development through post-market surveillance.
